SC 13G/A: BIOCRYST PHARMACEUTICALS INC
Ticker: BCRX · Form: SC 13G/A · Filed: Nov 7, 2024 · CIK: 882796
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by BIOCRYST PHARMACEUTICALS INC.
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on November 7, 2024 regarding BIOCRYST PHARMACEUTICALS INC (BCRX).